News
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
The Food and Drug Administration has approved the Novavax COVID-19 vaccine—with strict conditions. Coming after four years of ...
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...
The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...
FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...
Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...
A top agency official is meeting with industry and FDA staff as he works on guidance clarifying the FDA’s expectations for ...
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...
An FDA advisory committee is scheduled to meet to discuss the formula for the next COVID-19 vaccines after being sidelined ...
In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...
Makary did not reveal any specific details about the upcoming framework, but said it will outline the FDA's approach to vaccine approvals, providing companies with a clearer understanding of ...
The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results